Answers are grounded in this paper and cite their sources.
Objective To describe clinical-morphological features and outcomes of lupus podocytopathy (LP) and compare relapsing and non-relapsing (NR) forms. Methods Inclusion criteria for LP were SLE diagnosis and: 1) ISN/RPS Class I or Class II at kidney biopsy (KB); 2) with or without mesangial immunoglobulin/complement deposition; (3) >70% foot processes effacement at electron microscopy (EM). In the absence of EM, presence of nephrotic syndrome and complete remission to corticosteroids are needed. Complete remission: normal kidney function, proteinuria<0.5g/day; partial remission: persistence of non-nephrotic proteinuria. Results (tables 1 and 2) 26 patients (24 Females, median age 45 [16–53] years) were enrolled in this retrospective study. Nephrotic syndrome (84.6%), acute kidney injury (AKI) (38.5%) and arterial hypertension (41.7%) were the clinical presentations. Anti-DNA antibodies were positive in 62.5% of patients, C3 and C4 were low in 56% and 20% respectively. KB showed class I in 46.2%, class II in 53.8% and super-imposed focal segmental glomerulosclerosis in 15.4% of cases. 88.5% of patients received corticosteroids (oral or I.V.) associated with immunosuppressive drugs in 65.4% of cases. 24 patients achieved complete and 2 partial remission in a median of 4 (1–8.5) months. After 15 (range 3–65) months of remission, proteinuria (3.9[2.1–4.7]g/day) recurred in 7 patients (26.9%), all were re-treated and achieved remission again within 3 (1–10) months. The flare-free survival at 1,3 and 5 years were respectively 87.9%, 72.6% and 63.5%. At LP diagnosis, relapsing patients in comparison to NR patients tended to be older (46vs39 year-old), have higher serum creatinine (1.2vs0.8mg/dl,p=0.1), lower eGFR (58vs91ml/min/1.73m²,p=0.07) less frequent anti-DNA positivity (42.8%vs70.6%,P=0.08) and more frequent cutaneous manifestations (57.1vs11.1%,p=0.03). After a median follow-up of 59 (23–116) months, serum creatinine was 0.8 (0.64–0.92)mg/dl, eGFR was 91(83–103) ml/min/1.73m² and 24h proteinuria was 0.18(0.15–0.44)g. Two patients ended-up with mild kidney dysfunction (eGFR 37 and 58ml/min/1.73m²). Conclusions We showed that LP patients, despite minimal lesions at KB, presented clinical an immunologically active disease, supporting the hypothesis of LP being a distinct LN entity. Clinical manifestations rapidly responded to therapy but recurred in around 1/4 of patients. AKI and extrarenal SLE manifestations were more frequent in relapsing patients, suggesting that a more severe onset predisposed to recurrences.
No takes yet. Share an insight, caveat, or question.
Bonelli et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: